Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients
Keywords: 
Materias Investigacion::Ciencias de la Salud::Hepatología
COVID-19
SARS-CoV-2
Pneumonia
Epidemiology
Transplantation
Immunosuppression
Mycophenolate
Calcineurin inhibitors
Tacrolimus
Ever- olimus
Standardised incidence
Standardised mortality
Issue Date: 
2021
Publisher: 
Elsevier
ISSN: 
0168-8278
Citation: 
Colmenero, J. (Jordi); Rodriguez, M. (Manuel); Salcedo, M. (Magdalena); et al. "Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients". Journal of Hepatology. 74, 2021, 148 - 155
Abstract
In liver transplant patients, chronic immunosuppression increases the risk of acquiring COVID-19 but it could reduce disease severity. Com- plete immunosuppression with- drawal may not be justified. However, mycophenolate withdrawal or tem- porary conversion to calcineurin inhibitors or everolimus until disease resolution could be beneficial in hos- pitalised patients.

Files in This Item:
File
Epidemiological.pdf
Description
Size
1.06 MB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.